Revvity, Inc. (RVTY)
- Previous Close
90.42 - Open
91.58 - Bid --
- Ask --
- Day's Range
89.80 - 91.92 - 52 Week Range
88.53 - 129.50 - Volume
924,065 - Avg. Volume
1,205,106 - Market Cap (intraday)
10.796B - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
37.85 - EPS (TTM)
2.42 - Earnings Date Jul 28, 2025 - Aug 1, 2025
- Forward Dividend & Yield 0.28 (0.31%)
- Ex-Dividend Date Jul 18, 2025
- 1y Target Est
124.44
Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company's Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for use in oncology, screening newborns for rare genetic conditions, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BioQule, BoBs, chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPatternTM, Evolution Evoya, explorer, Fontus, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Omni Bead Ruptor, Omni Bead Ruptor Elite, Omni Tip, Pannoramic, Panthera Puncher, PG-Seq, PG-Find, PreNAT II, Prime, Protein Clear, ProteinEXact, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord, VICTOR2D, and Zephyr brands. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
www.revvity.com11,000
Full Time Employees
December 29
Fiscal Year Ends
Sector
Industry
Recent News: RVTY
View MorePerformance Overview: RVTY
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RVTY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RVTY
View MoreValuation Measures
Market Cap
10.80B
Enterprise Value
12.98B
Trailing P/E
37.85
Forward P/E
18.52
PEG Ratio (5yr expected)
0.68
Price/Sales (ttm)
4.03
Price/Book (mrq)
1.41
Enterprise Value/Revenue
4.69
Enterprise Value/EBITDA
15.34
Financial Highlights
Profitability and Income Statement
Profit Margin
10.35%
Return on Assets (ttm)
2.09%
Return on Equity (ttm)
3.82%
Revenue (ttm)
2.77B
Net Income Avi to Common (ttm)
296.04M
Diluted EPS (ttm)
2.42
Balance Sheet and Cash Flow
Total Cash (mrq)
1.14B
Total Debt/Equity (mrq)
43.54%
Levered Free Cash Flow (ttm)
750.5M